Daxas
- Product Details
- Company Profile
1. The overview of Daxas
Roflumilast(Daxas or BYK 20869) is a selective, long-acting the enzyme PDE-4 inhibitor with an IC50 of 0.8 nM in HANGZHOU HOLYPHARM BIOTECH CO.,LTD. Daxas is a drug which acts as a selective, long-acting inhibitor of the enzyme PDE-4. It has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs. In March 2011, Daliresp gained FDA approval in the US for reducing COPD exacerbations.
2. What is COPD?
COPD is an under-diagnosed progressive lung disease that may lead to death. Worldwide, COPD kills four people every minute and the World Health Organization (WHO) predicts that it will be the third leading cause of death by 2030. WHO estimates that 80 million people have moderate to severe COPD.
3. The Preparation of Roflumilast:
Roflumilast Preparation is as follows:
4. Daxas 500microgram tablets
Daxas 500microgram tablets is an anti-inflammatory medicine and is used in the treatment of chronic obstructive airways disease. It works by blocking the action of some of the chemicals that cause inflammation in the lungs. It is used in combination with bronchodilators. When to take this medicine, please talk to your prescriber or pharmacist and take it correctly.
Verified Supplier
HANGZHOU HOLYPHARM BIOTECH CO.,LTD
- Country: China (Mainland)
- Year Established: 2009
- Business License:
- Business type: Other
- Integral:
Contact Details|Similar Products
Escrow ServiceMore
Secure Your Orders With escrow More Transparency,Less Uncertainty